IMMUNOGENITÄTSVORHERSAGEVORRICHTUNG, IMMUNOGENITÄTSVORHERSAGEVERFAHREN UND COMPUTERPROGRAMM FÜR SYNTHETISCHES LANGES PEPTIDDESIGN

Patent europeic · EP4328919 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4328919
Numer da la dumonda
EP23171753
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
05-05-2023
Publitgà
28-02-2024
Concedì
22-07-2026
La protecziun finescha il pli tard
04-05-2043
Proxima taxa annuala scadenta
31-05-2027
Classas IPC
G16B 35/00 (2019.01)
G16B 20/30 (2019.01)
G16B 30/00 (2019.01)
G16B 40/20 (2019.01)
A61K 39/00 (2006.01)
Prioritad
KR 20220105655 23.08.2022
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 22-07-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 22.07.2026

Partidas

Possessur

Theragen Bio Co., Ltd.

(Sampyeong-dong, Korea Bio Park Bldg) C-4F, 700, Daewangpangyo-ro Bundang-gu Seongnam-si, Gyeonggi-do 13488, KR

Inventur

HWANG, Tae soon

Seongnam-si, KR

PAIK, Soon Myung

Seongnam-si, KR

HONG, Seong Eui

Seongnam-si, KR

KIM, Hae Suk

Seongnam-si, KR

NOH, Eon Ji

Seongnam-si, KR

JUNG, Min Ho

Seongnam-si, KR

KIM, Seong Gwang

Seongnam-si, KR

KIM, In Young

Seongnam-si, KR

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.